共病-多重用药评分可预测血管外科术后结局与死亡
该回顾性单中心研究纳入466例接受颈动脉内膜剥脱术、腹股沟下旁路术、下肢经皮血运重建术或腹主动脉瘤腔内修复术的患者,评估共病-多重用药评分(CPPS)与术后结局及死亡的关系。结果显示CPPS与住院时间延长独立相关,并与1年和5年死亡率独立相关(HR=2.2,95%CI:1.3-3.3),ROC曲线下面积分别为0.81和0.72。
要点
- CPPS由药物数和共病数相加得出,客观易用。
- CPPS越高,住院和术后住院时间越长(P<0.001)。
- CPPS是1年和5年死亡的独立预测因素。
核心结论
- CPPS是量化常见血管外科术后结局和死亡风险的简便实用临床工具。
研究设计与样本
- 回顾性单中心研究,共纳入466例接受颈动脉内膜剥脱术、腹股沟下旁路术、下肢经皮血运重建术或腹主动脉瘤腔内修复术的患者。
主要发现
- 术前平均CPPS为14.1±6.1。
- CPPS越高,住院和术后住院时间越长(P<0.001)。
- 严重和病态CPPS类别患者ICU入住、再干预和30天再入院率较高,但多重比较校正后未达统计学显著性。
- 多变量Cox模型显示CPPS与1年和5年死亡率独立相关(HR=2.2,95%CI:1.3-3.3)。
- ROC分析显示CPPS预测1年和5年全因死亡的C统计量分别为0.81和0.72(P<0.001)。
关键数值与推荐
- CPPS按评分分为轻度(0-7分)、中度(8-15分)、重度(15-21分)和病态(≥21分)。
临床怎么用
- CPPS可用于血管外科术前风险分层,辅助识别术后死亡高风险患者。
- CPPS可作为资源分配和出院计划的辅助工具。
局限性
- 需要进一步研究验证CPPS在改善现有结局预测因素方面的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The comorbidity-polypharmacy score (CPPS) was developed to quantify the severity of comorbidities of patients with geriatric trauma. CPPS is the sum of the number of medications and comorbidities, and is thus objective, user-friendly, and potentially adaptable to many clinical situations. We sought to understand if CPPS associates with outcomes and mortality after common vascular surgery procedures. METHODS: This is a retrospective single-center study. A total of 466 patients who underwent carotid endarterectomy, infrainguinal bypass, percutaneous lower extremity revascularization, or endovascular abdominal aortic aneurysm repair at a single medical center were included. CPPS were classified as mild, moderate, severe, and morbid based on scores of 0-7, 8-15, 15-21, and ≥21, respectively. End points were reinterventions, 30-day readmission, and mortality. We used chi-squared tests to analyze differences in categorical variables; Kruskal-Wallis tests to analyze differences in continuous variables; Kaplan-Meier estimation and Cox proportional hazard modeling to examine survival data; and receiver operator characteristic (ROC) curve analyses to assess sensitivity and specificity. RESULTS: The mean preoperative CPPS was 14.1 ± 6.1. Higher CPPS were associated with longer hospital and postoperative length of stay (P < 0.001). Severe and morbid CPPS categories had higher rates of ICU admission, reintervention, and 30-day readmission which did not reach statistical significance after correction for multiple comparisons. CPPS was independently associated with 1- and 5-year mortality in a multivariable Cox model (hazard ratio = 2.2, 95% confidence interval: 1.3-3.3). ROC analysis revealed C-statistics of 0.81 and 0.72 for 1-year and 5-year all-cause mortality, respectively (P < 0.001). CONCLUSIONS: CPPS is a simple and pragmatic clinical tool for quantifying risk of postoperative outcomes and mortality after common vascular surgery procedures. Further investigation is needed to validate the use of CPPS in enhancing existing predictors of patient outcomes and in serving as an adjunctive tool for determining resource allocation and discharge planning in patients who underwent vascular surgery.
引用
- Khanh LN, Helenowski IB, Hoel AW, et al. The Comorbidity-Polypharmacy Score is an Objective and Practical Predictor of Outcomes and Mortality after Vascular Surgery. Ann Vasc Surg. 2020. PMID: 32502672. doi:10.1016/j.avsg.2020.05.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。